About Us - Matregenix

Our Story

At Matregenix, we have always been fascinated by the potential of nanofibers and their ability to revolutionize a wide range of industries. From filtration to biomedical applications, we knew that these tiny fibers had the power to make a big impact. In 2018, we began our journey in Boston as a small company with a big vision-to design, develop, and manufacture highly tunable nanofibrous materials that could be customized to meet the specific needs of various applications. Our R&D efforts have led us to create a range of materials that can be used in a wide range of fields. We then expanded our manufacturing capabilities by relocating our operation to Irvine, California.

But we didn't stop there. We realized that to truly unlock the potential of nanofibers, we needed to provide manufacturers with the tools and resources they needed to bring these innovations to life. That's why we began building state-of-the-art electrospinning machines and offering contract development and manufacturing services to help manufacturers turn their ideas into products.

Today, Matregenix has grown into a leading provider of nanofibrous materials and electrospinning equipment. We have a strong reputation for our ability to customize our materials to meet the unique needs of our clients, and our contract development and manufacturing services have helped many companies bring their nanofiber innovations to market. We are proud of what we have accomplished, but we know that there is still so much more to be done. We are constantly pushing the boundaries of what is possible with nanofibers, and we are committed to continuing to innovate and evolve as a company.

Join us on our journey to unlock the potential of nanofibers and make a big impact across various industries.

Our Resources

Matregenix recently expanded its operations into a new 10,000-square-foot manufacturing facility located in Mission Viejo, California. The new facility is equipped with state-of-the-art clean rooms designed for clinical-grade manufacturing, alongside fully outfitted laboratories, supporting our commitment to high-quality manufacturing standards. The site features advanced industrial-scale nanofiber assembly lines and pilot roll-to-roll machines, along with versatile lab-scale machines that can accommodate multiple target collectors such as flat surfaces, drums, and mandrels. Comprehensive analytical capabilities are ensured by the inclusion of essential microstructure characterization tools, including a scanning electron microscope (SEM).

Our Team

Matregenix is composed of a team of material scientists, quality engineers, and regulatory affairs professionals who possess a wealth of experience in developing nanofibrous polymeric materials for a wide range of applications. Our deep know-how in synthetic chemistry and material processing allows us to quickly iterate formulations to meet specific target product profiles, achieving desired results efficiently and effectively. Our collective proven track record in commercializing nanofiber materials for a diverse range of applications is a testament to our expertise and our commitment to innovation and excellence.

Leadership

Sherif Soliman

Ph.D., MBA - Chief Executive Officer

Set up an appointment with me

Sherif Soliman

Ph.D., MBA - Chief Executive Officer

Highly passionate, and quality-driven, Dr. Sherif Soliman is a leading Material Scientist and founder of Matregenix. For over 20 years, Sherif has built on his extensive experience in biomaterials and nanofibers research and has planned, designed, and executed numerous nanofibrous polymeric structures for medical applications. His historical achievements in the creation of tissue scaffolds, as well as his expertise in medical device manufacturing, have earned him a reputation as a trusted partner to thought leaders and industry experts throughout the globe. One of his most rewarding achievements took place when a tissue-engineered scaffold he designed and developed became the first synthetic whole organ in medical history to be implanted into a patient.

As a native of the Sinai desert of Egypt, Sherif felt called to make difference beyond his home country and has always admired medical innovations and the strong correlation between science and engineering.

Sherif holds a Ph.D. in Material Science and Engineering from the University of Rome Tor Vergata, though much of his research was conducted as a visiting research fellow at Harvard Medical School. Following that, Sherif completed postdoctoral fellowships, the first one at MIT, and the second was an eminent T32 fellowship from NIH at Princeton University. Sherif also graduated from the Executive MBA program at Questrom School of Business and earned a BS in Biomedical Engineering. He holds several patents and has authored many peer-reviewed research papers in top tier journals. Recently, Sherif volunteered to author a new ASTM guideline for the characterization of fiber-based scaffolds for tissue engineering medical products.

When he’s not in the office, Sherif enjoys spending time with his wife and three children, being outdoors, and playing soccer as much as he can.

Set up an appointment with me

Kevin Guo

Ph.D. - Chief Operating Officer

Set up an appointment with me

Kevin Guo

Ph.D. - Chief Operating Officer

Dr. Guo is an exceptionally innovative Research and Development Scientist with a mastery in nanotechnologies and microfluidic fabrication. With over eight years of multidisciplinary research experience, Kevin has profound expertise in scientific research, laboratory management, analytical technology, scientific literature, and instrumentation, making him a suburb resource to cultivate ideal operational improvements that foster business growth.

Kevin brings a very thunderous, naturistic approach to the Matregenix culture. He has always been ardent about the environment and protecting the planet, and aims to create a sustainable future using novel technologies. Because Kevin has been so powerfully motivated by this rooted mission throughout his life, while earning his Ph.D. in Chemical Engineering from the University of Wyoming, he designed all his experiments and tracked his Department of Energy projects in order to mitigate climate change. As someone with a passion for the environment and being at the forefront of medical innovation, it is no secret that Kevin genuinely admires his roles, and is continuously improving himself both personally and professionally to deliver valuable, scientific advancements that result in lasting impacts for the human race.

Set up an appointment with me

Ed O’Sullivan

J.D., MBA- Director of Business Development

Ed O’Sullivan

J.D., MBA- Director of Business Development

Ed O’Sullivan is a seasoned entrepreneur with a robust track record of building, buying, and selling businesses. With years of experience in the business development landscape, Ed has become a trusted advisor to numerous startups and small enterprises, offering strategic guidance and counsel to foster their growth and success.

For over 17 years, Ed has owned and operated Payer Tech, an innovative IT company specializing in claims transaction services for the healthcare insurance industry. Under his leadership, Payer Tech has become a trusted partner for healthcare providers and insurers, delivering efficient and reliable solutions that streamline claims processing and enhance operational efficiency.

Ed's entrepreneurial journey is marked by his keen ability to identify market opportunities and drive business transformation. He has a deep understanding of the challenges and opportunities that startups face and leverages his extensive knowledge to help them navigate complex business environments. His expertise in business strategy, combined with his legal and financial acumen, has enabled him to successfully lead numerous ventures to sustainable growth and profitability.

In his role as Director of Business Development, Ed continues to apply his strategic vision and entrepreneurial spirit to foster innovation and drive business growth. His commitment to excellence and passion for helping businesses thrive make him an invaluable asset to any organization.

Stephen Bumb

Chief Commercialization Officer

Stephen Bumb

Chief Commercialization Officer

Stephen is a seasoned senior healthcare technologies marketing executive with extensive experience in driving the commercialization of innovative technologies for emerging companies. Over his illustrious career, Stephen has played a pivotal role in the senior leadership teams of five startups, guiding them through critical growth phases and market entry. His expertise also extends to transforming business strategies at Fortune 500 companies, including industry giants like Edwards Lifesciences and Canon Medical.

Throughout his career, Stephen has demonstrated a remarkable ability to engage with a diverse range of clinical disciplines, having worked closely with over 20 different specialties. His leadership has been instrumental in the successful commercialization of more than 25 major product platforms, underscoring his deep understanding of the healthcare market and his strategic acumen.

Currently, Stephen serves as the Principal of AR-TIC-U-LATE Medtech, a consultancy firm dedicated to providing comprehensive Go To Market strategy design and execution services for emerging medical technology companies. His passion for innovation and commitment to excellence continue to drive his mission to support the next generation of medical advancement.

Advisory Board

Michael Francis

Ph.D.

Dr. Francis, Asante Bio CEO, co-founded Embody Inc, sold to Zimmer Biomet for $275M. He invented platform electrospinning and led R&D to commercialization. He secured $25M in DARPA, NIH and NSF grants, and raised $32M in investor funds. With 80+ patents, he has led teams developing advanced regenerative medicine and nanotechnology from concept to clinic.

Matthew Becker

Ph.D.

Dr. Matthew Becker is the Hugo L. Blomquist Distinguished Professor at Duke University, focusing on bioactive polymers in chemistry, materials, and medicine. Awarded the 2019 Carl S. Marvel Award, he's a Kavli Fellow. Becker was the W. Gerald Austen Endowed Chair at The University of Akron (2009-2019). He earned his Ph.D. in organic chemistry from Washington University in 2003 and worked at NIST until 2009.

Fauad Hasan

Fauad is a chemical engineer with over 22 years of experience in the biopharmaceutical and medical device industry. He co-founded Bonti, which was acquired by Allergan for $195 million. Fauad was an executive at Allergan and held positions at Baxter and Regeneron. He is currently working on his next venture, Ornovi, in Orange County and serves on the boards of Biopharm and OCTANe.

Omer Merhi

Ph.D.

Former head of clinical and project management at Smith & Nephew, Sobi, Abiomed, Novartis, Abbott, Boston Scientific, and 3M, with a proven record in leading clinical operations and CROs. Known for positive leadership, budget and Master Service Agreement negotiations, and strategic planning in rare diseases, infectious diseases, cardiovascular, structural heart, hemodynamics, and orthopedics. Skilled in developing protocols, presentations, and establishing KOL and internal stakeholder relationships.

Kelly Kambs

Ph.D., MBA

Highly accomplished, performance-driven chief executive, with over 25 years of experience in the building products and services industries with highly diverse market segments and companies, including Johns Manville, USG, PPG, Masco and ServiceMaster. Possesses in-depth understanding of change management and executive team development. Expert in maximizing value creation through innovative growth and operationally efficiency.

Mohamed Kamel,

DMD.

Dr. Kamel is licensed to practice dentistry in Massachusetts and Illinois. In addition to his dental expertise, Dr. Kamel has an extensive background in Biomedical Engineering research, with a particular interest in tissue engineering, nano-scaffolding, and stem cells bioengineering. He holds both a bachelor's and a master's degree in biomedical engineering from Boston University.

Samir Shreim

PhD.

Dr. Samir Shreim is a Scientist-Entrepreneur focused on bringing novel, multi-disciplinary products to market. He co-founded and led Cactus Medical, developing a non-invasive otoscope for pediatric ear health. Building on this experience, he founded Aly Development, creating an innovation platform with multiple verticals. With a background in Biomedical Engineering and 17 years in the industry, he has extensive experience in medical technology development, including automation engineering at Applied Medical Resources. Dr. Shreim is skilled in managing federal awards and driving commercial partnerships.

Marco C. Bottino

DDS, MSc, PhD, FADM

Dr. Marco Bottino is the Robert W. Browne Endowed Professor of Dentistry at the University of Michigan, directing research in CRSE and the Postgraduate Program in Regenerative Dentistry. A principal investigator with NIH grants, he has received multiple awards, including the IADR Centennial Emerging Leader Award. He reviews for nearly 30 journals, served on the NIH MTE study section, and is an elected Fellow of the Academy of Dental Materials. Dr. Bottino has published over 140 peer-reviewed papers in regenerative medicine and biomaterials.

JP Powers

MBA.

JP Powers has over 15 years of experience in investment management, with a demonstrated history of working in the law practice industry. He is an experienced Portfolio Manager known for his expertise in portfolio management, asset management, investment strategies, fixed income, and equities. JP has built a strong reputation as a finance professional, adept at navigating complex financial landscapes and delivering strategic investment solutions to clients. His extensive background and skills make him a valuable asset in the field of investment management.